The proband, identified during family follow-up, had recurrent mucocutaneous infections, marked CD4+ lymphopenia with CD4/CD8 inversion, and near-absent HLA-DR on B cells; he was started on monthly intravenous immunoglobulin and trimethoprim–sulfamethoxazole prophylaxis. This evidence concerns the gene CD8A and lymphopenia.